These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Chinese expert consensus on gastroenteropancreatic neuroendocrine neoplasms (2022 edition)]. Expert Committee on Neuroendocrine Neoplasms, Chinese Society of Clinical Oncology. Zhonghua Zhong Liu Za Zhi; 2022 Dec 23; 44(12):1305-1329. PubMed ID: 36575783 [Abstract] [Full Text] [Related]
4. Gastroenteropancreatic neuroendocrine neoplasms: current development, challenges, and clinical perspectives. Zhang XB, Fan YB, Jing R, Getu MA, Chen WY, Zhang W, Dong HX, Dakal TC, Hayat A, Cai HJ, Ashrafizadeh M, Abd El-Aty AM, Hacimuftuoglu A, Liu P, Li TF, Sethi G, Ahn KS, Ertas YN, Chen MJ, Ji JS, Ma L, Gong P. Mil Med Res; 2024 Jun 04; 11(1):35. PubMed ID: 38835066 [Abstract] [Full Text] [Related]
5. Models of Gastroenteropancreatic Neuroendocrine Neoplasms: Current Status and Future Directions. Detjen K, Hammerich L, Özdirik B, Demir M, Wiedenmann B, Tacke F, Jann H, Roderburg C. Neuroendocrinology; 2021 Jun 04; 111(3):217-236. PubMed ID: 32615560 [Abstract] [Full Text] [Related]
6. Gastroenteropancreatic neuroendocrine neoplasms: epidemiology, genetics, and treatment. Tan B, Zhang B, Chen H. Front Endocrinol (Lausanne); 2024 Jun 04; 15():1424839. PubMed ID: 39411312 [Abstract] [Full Text] [Related]
10. Molecular and cell biological aspects of neuroendocrine tumors of the gastroenteropancreatic system. Wiedenmann B, John M, Ahnert-Hilger G, Riecken EO. J Mol Med (Berl); 1998 Aug 04; 76(9):637-47. PubMed ID: 9725766 [Abstract] [Full Text] [Related]
14. Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine neoplasms in a Chinese population: a large, retrospective single-centre study. Zhang M, Zhao P, Shi X, Zhao A, Zhang L, Zhou L. BMC Endocr Disord; 2017 Jul 13; 17(1):39. PubMed ID: 28705205 [Abstract] [Full Text] [Related]
15. Immunotherapies for well-differentiated grade 3 gastroenteropancreatic neuroendocrine tumors: A new category in the World Health Organization classification. Xu JX, Wu DH, Ying LW, Hu HG. World J Gastroenterol; 2021 Dec 21; 27(47):8123-8137. PubMed ID: 35068858 [Abstract] [Full Text] [Related]
16. Current status of Interventional Radiology in the management of Gastro-Entero-Pancreatic Neuroendocrine Tumours (GEP-NETs). Orgera G, Krokidis M, Cappucci M, Gourtsoyianni S, Tipaldi MA, Hatzidakis A, Rebonato A, Rossi M. Cardiovasc Intervent Radiol; 2015 Feb 21; 38(1):13-24. PubMed ID: 25366087 [Abstract] [Full Text] [Related]
18. JNETS clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms: diagnosis, treatment, and follow-up: a synopsis. Ito T, Masui T, Komoto I, Doi R, Osamura RY, Sakurai A, Ikeda M, Takano K, Igarashi H, Shimatsu A, Nakamura K, Nakamoto Y, Hijioka S, Morita K, Ishikawa Y, Ohike N, Kasajima A, Kushima R, Kojima M, Sasano H, Hirano S, Mizuno N, Aoki T, Aoki T, Ohtsuka T, Okumura T, Kimura Y, Kudo A, Konishi T, Matsumoto I, Kobayashi N, Fujimori N, Honma Y, Morizane C, Uchino S, Horiuchi K, Yamasaki M, Matsubayashi J, Sato Y, Sekiguchi M, Abe S, Okusaka T, Kida M, Kimura W, Tanaka M, Majima Y, Jensen RT, Hirata K, Imamura M, Uemoto S. J Gastroenterol; 2021 Nov 21; 56(11):1033-1044. PubMed ID: 34586495 [Abstract] [Full Text] [Related]
19. Advances and Current Concepts in the Medical Management of Gastroenteropancreatic Neuroendocrine Neoplasms. Alexandraki KI, Karapanagioti A, Karoumpalis I, Boutzios G, Kaltsas GA. Biomed Res Int; 2017 Nov 21; 2017():9856140. PubMed ID: 29349087 [Abstract] [Full Text] [Related]